{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:53:40Z","timestamp":1792601620985,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-10861-2","type":"journal-article","created":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T13:40:46Z","timestamp":1744378846000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The impact of a comprehensive strategy on HIV treatment continuum in a highly endemic area of China: an interrupted time series analysis"],"prefix":"10.1186","volume":"25","author":[{"given":"Ruiying","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangfang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houlin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Decai","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiejun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongfu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,11]]},"reference":[{"issue":"48","key":"10861_CR1","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.46234\/ccdcw2021.250","volume":"3","author":"ZF Liu","year":"2021","unstructured":"Liu ZF, Tang XF, Liu YF, Zhang LL, Yang YH, Zheng YL, et al. HIV Prevention and Health Poverty Alleviation - Liangshan Prefecture, Sichuan Province, China, 2017\u20132020[J]. China CDC Wkly. 2021;3(48):1031\u20135.","journal-title":"China CDC Wkly"},{"issue":"4","key":"10861_CR2","first-page":"345","volume":"24","author":"LH Liu","year":"2018","unstructured":"Liu LH, Liu L, Yu G, Hu Y, Liang L, Pei XD, et al. Epidemic characteristics and trend among newly reported HIV cases in Liangshan prefecture from\u00a02005 to 2016. Chin J AIDS STD. 2018;24(4):345-347,356.","journal-title":"Chin J AIDS STD."},{"issue":"2","key":"10861_CR3","first-page":"328","volume":"42","author":"QX Wang","year":"2015","unstructured":"Wang QX, Gong YH, Nan L, Ma MJ, Yin BB, Ma ZJ, et al. Analysis on the results of sampling survey for HIV infection among rural population in 14 counties of Liangshan prefecture[J]. Mod Prev Med. 2015;42(2):328-331,350.","journal-title":"Mod Prev Med."},{"issue":"6","key":"10861_CR4","first-page":"668","volume":"52","author":"JL Xu","year":"2018","unstructured":"Xu JL, Jike CN, Ma Y, Yu G, Wang J, Wang K, et al. Effects and associated factors of HIV\/AIDS anti retroviral therapy in Liangshan Yi Autonomous Prefecture, Sichuan Province[J]. Chin J Prev Med. 2018;52(6):668\u201372.","journal-title":"Chin J Prev Med"},{"issue":"10","key":"10861_CR5","first-page":"1313","volume":"38","author":"H Yu","year":"2022","unstructured":"Yu H, Wang J, He L, Zeng YL, Mao A, Zhuo-ma LC, et al. Analysis of antiviral treatment effect and its influencing factors in HIV high prevalence counties of Liangshan Prefecture[J]. J Prev Med Inf. 2022;38(10):1313\u201320.","journal-title":"J Prev Med Inf"},{"issue":"6","key":"10861_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0005790","volume":"4","author":"MWG Brinkhof","year":"2009","unstructured":"Brinkhof MWG, Pujades-Rodriguez M, Egger M. Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis. PLoS ONE. 2009;4(6): e5790.","journal-title":"PLoS ONE"},{"issue":"9","key":"10861_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001874","volume":"12","author":"Z Wu","year":"2015","unstructured":"Wu Z, Zhao Y, Ge X, Mao Y, Tang Z, Shi CX, et al. Simplified HIV Testing and Treatment in China: analysis of mortality rates before and after a structural intervention. PLoS Med. 2015;12(9): e1001874.","journal-title":"PLoS Med"},{"issue":"8","key":"10861_CR8","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1080\/09540121.2018.1554238","volume":"31","author":"YY Wang","year":"2019","unstructured":"Wang YY, Jin Y, Chen C, Zheng W, Wang SB, Ungvari GS, et al. Meta-analysis of adherence to highly active antiretroviral therapy in patients with HIV infection in China. AIDS Care. 2019;31(8):913\u201322.","journal-title":"AIDS Care"},{"key":"10861_CR9","first-page":"CD008272","volume":"3","author":"N Siegfried","year":"2010","unstructured":"Siegfried N, Uthman OA, Rutherford GW. Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV-infected, treatment-naive adults. Cochrane Database Syst Rev. 2010;3:CD008272.","journal-title":"Cochrane Database Syst Rev."},{"issue":"Suppl 3","key":"10861_CR10","doi-asserted-by":"publisher","first-page":"S85","DOI":"10.1086\/651478","volume":"50","author":"MS Cohen","year":"2010","unstructured":"Cohen MS, Gay CL. Treatment to prevent transmission of HIV-1. Clin Infect Dis. 2010;50(Suppl 3):S85-95.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10861_CR11","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1056\/NEJMoa1105243","volume":"365","author":"MS Cohen","year":"2011","unstructured":"Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy[J]. N Engl J Med. 2011;365(6):493\u2013505.","journal-title":"N Engl J Med"},{"issue":"9657","key":"10861_CR12","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/S0140-6736(08)61697-9","volume":"373","author":"RM Granich","year":"2009","unstructured":"Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet. 2009;373(9657):48\u201357.","journal-title":"Lancet"},{"key":"10861_CR13","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s40249-023-01119-7","volume":"12","author":"XS Wu","year":"2023","unstructured":"Wu XS, Wu GH, Ma P, Wang RG, Li LH, Sun YH, et al. Immediate and long-term outcomes after treat-all among people living with HIV in China: an interrupted time series analysis. Infect Dis Poverty. 2023;12:73.","journal-title":"Infect Dis Poverty"},{"issue":"10","key":"10861_CR14","first-page":"1307","volume":"38","author":"W Yang","year":"2022","unstructured":"Yang W, Yuan YW, Huang X, Huang YL, Zhuo-Ma LC, Zeng YL, et al. Timeliness and influencing factors of antiviral treatment for HIV\/AIDS patients in Liangshan Prefecture[J]. J Prev Med Inf. 2022;38(10):1307-1312,1320.","journal-title":"J Prev Med Inf"},{"key":"10861_CR15","unstructured":"Sichuan Provincial People's Government. Notice on Forwarding the 'First Phase Action Plan for HIV Prevention and Health Poverty Alleviation in Liangshan Prefecture (2017\u20132020)'. 2017."},{"issue":"12","key":"10861_CR16","first-page":"1339","volume":"28","author":"YF Liu","year":"2022","unstructured":"Liu YF, Tang XF, Han MJ, Jike C, Yang YH, Qu MX, et al. Achievements and prospects of AIDS Prevention and Health Poverty Alleviation in Liangshan Prefecture[J]. Chin J AIDS STD. 2022;28(12):1339\u201344.","journal-title":"Chin J AIDS STD."},{"issue":"3","key":"10861_CR17","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-030228","volume":"10","author":"D Onoya","year":"2020","unstructured":"Onoya D, Sineke T, Hendrickson C, Mokhele I, Maskew M, Long LC, et al. Impact of the test and treat policy on delays in antiretroviral therapy initiation among adult HIV positive patients from six clinics in Johannesburg, South Africa: results from a prospective cohort study. BMJ Open. 2020;10(3): e30228.","journal-title":"BMJ Open"},{"issue":"4","key":"10861_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25279","volume":"22","author":"J Ross","year":"2019","unstructured":"Ross J, Sinayobye JDA, Yotebieng M, Hoover DR, Shi Q, Ribakare M, et al. Early outcomes after implementation of treat all in Rwanda: an interrupted time series study. J Int AIDS Soc. 2019;22(4): e25279.","journal-title":"J Int AIDS Soc"},{"issue":"3","key":"10861_CR19","doi-asserted-by":"publisher","first-page":"e1004367","DOI":"10.1371\/journal.pmed.1004367","volume":"21","author":"E Brazier","year":"2024","unstructured":"Brazier E, Tymejczyk O, Wools-Kaloustian K, Jiamsakul A, Torres MTL, Lee JS, et al. Long-term HIV care outcomes under universal HIV treatment guidelines: A retrospective cohort study in 25 countries. PLoS Med. 2024;21(3):e1004367.","journal-title":"PLoS Med."},{"key":"10861_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0268226","volume":"17","author":"L Mugenyi","year":"2022","unstructured":"Mugenyi L, Nanfuka M, Byawaka J, Agaba C, Mijumbi A, Kagimu D, et al. Effect of universal test and treat on retention and mortality among people living with HIV-infection in Uganda: An interrupted time series analysis. PLoS ONE. 2022;17: e0268226.","journal-title":"PLoS ONE"},{"issue":"12","key":"10861_CR21","first-page":"1211","volume":"25","author":"J Ma","year":"2019","unstructured":"Ma J, Luo Y, Chen Y, Dong X, Zhao Y. Factors influencing \u201cimmediate treatment after diagnosis\u201d of heterosexual HIV infection in two cities in Yunnan Province. Chin J AIDS STD. 2019;25(12):1211\u20134.","journal-title":"Chin J AIDS STD"},{"issue":"9","key":"10861_CR22","first-page":"756","volume":"22","author":"J Xu","year":"2016","unstructured":"Xu J, Mao Y. Current status and prospect of China\u2019s national HIV\/AIDS comprehensive response information management system (CRIMS). Chin J AIDS STD. 2016;22(9):756\u20138.","journal-title":"Chin J AIDS STD"},{"issue":"1","key":"10861_CR23","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1186\/s12889-021-10580-8","volume":"21","author":"CY Wu","year":"2021","unstructured":"Wu CY, Zhang BY, Dai Z, Zheng QW, Duan ZH, He QY, et al. Impact of immediate initiation of antiretroviral therapy among men who have sex with men infected with HIV in Chengdu, southwest China: trends analysis 2008\u20132018. BMC Public Health. 2021;21(1):689.","journal-title":"BMC Public Health"},{"key":"10861_CR24","unstructured":"National Center for AIDS\/STD Control and Prevention, Chinese Center for Disease Control and Prevention. China free antiretroviral treatment manual. Beijing: People' s Medical Publishing House, 2016."},{"issue":"1","key":"10861_CR25","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1093\/cid\/ciy400","volume":"68","author":"Y Zhao","year":"2019","unstructured":"Zhao Y, Wu ZY, Mcgoogan JM, Sha YY, Zhao DC, Ma Y, et al. Nationwide cohort study of antiretroviral therapy timing: treatment dropout and virological failure in China, 2011\u20132015[J]. Clin Infect Dis. 2019;68(1):43\u201350.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10861_CR26","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/S1473-3099(11)70097-4","volume":"11","author":"FJ Zhang","year":"2011","unstructured":"Zhang FJ, Dou ZH, Ma Y, Zhang Y, Zhao Y, Zhao DC, et al. Effect of earlier initiation of antiretroviral treatment and increased treatment coverage on HIV-related mortality in China: a national observational cohort study. Lancet Infect Dis. 2011;11(7):516\u201324.","journal-title":"Lancet Infect Dis"},{"key":"10861_CR27","unstructured":"Che SS, Huang YL, Zeng YL, Yang W, Ren JH, Zhang Qin, et al. Analysis of the effect and influencing factors of antiviral treatment among HIV\/AIDS patients in Liangshan Prefecture from 2010 to 2019. J Prev Med Inf;2022,38(10):1321\u20131328."},{"issue":"3","key":"10861_CR28","doi-asserted-by":"publisher","first-page":"e158","DOI":"10.1016\/S2352-3018(20)30359-3","volume":"8","author":"J Dorward","year":"2021","unstructured":"Dorward J, Khubone T, Gate K, Ngobese H, Sookrajh Y, Mkhize S, et al. The impact of the COVID-19 lockdown on HIV care in 65 South African primary care clinics: an interrupted time series analysis. Lancet HIV. 2021;8(3):e158\u201365.","journal-title":"Lancet HIV"},{"issue":"3","key":"10861_CR29","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1093\/ije\/dyaa148","volume":"50","author":"H Xiao","year":"2021","unstructured":"Xiao H, Augusto O, Wagenaar BH. Reflection on modern methods: acommon error in the segmented regression parameterization of interrupted time-series analyses. Int J Epidemiol. 2021;50(3):1011\u20135.","journal-title":"Int J Epidemiol"},{"key":"10861_CR30","volume":"29","author":"X Wu","year":"2022","unstructured":"Wu X, Wu G, Ma Y, Huang X, Yang Y, Cai Y, et al. The impact of COVID-19 non-pharmaceutical interventions on HIV care continuum in China: An interrupted time series analysis. Lancet Reg Health West Pac. 2022;29: 100569.","journal-title":"Lancet Reg Health West Pac"},{"key":"10861_CR31","doi-asserted-by":"publisher","DOI":"10.2196\/40591","volume":"9","author":"X Wu","year":"2023","unstructured":"Wu X, Zhou X, Chen Y, Zhai K, Sun R, Luo G, et al. The impact of COVID-19 lockdown on cases of and deaths from aids, gonorrhea, syphilis, hepatitis B, and hepatitis C: interrupted time series analysis. JMIR Public Health Surveill. 2023;9: e40591.","journal-title":"JMIR Public Health Surveill"},{"issue":"1","key":"10861_CR32","first-page":"348","volume":"46","author":"JL Bernal","year":"2017","unstructured":"Bernal JL, Cummins S, Gasparrini A. Interrupted time series regression for the evaluation of public health interventions: a tutorial. Int J Epidemiol. 2017;46(1):348\u201355.","journal-title":"Int J Epidemiol"},{"issue":"1","key":"10861_CR33","doi-asserted-by":"publisher","first-page":"20180010","DOI":"10.1515\/em-2018-0010","volume":"8","author":"C Bottomley","year":"2019","unstructured":"Bottomley C, Scott JAG, Isham V. Analysing interrupted time series with a control. Epidemiol Methods. 2019;8(1):20180010.","journal-title":"Epidemiol Methods"},{"key":"10861_CR34","doi-asserted-by":"publisher","first-page":"e539","DOI":"10.1016\/S2352-3018(16)30090-X","volume":"3","author":"G Amanyire","year":"2016","unstructured":"Amanyire G, Semitala FC, Namusobya J, Katuramu R, Kampiire L, Wallenta J, et al. Effects of a multicomponent intervention to streamline initiation of antiretroviral therapy in Africa: a stepped-wedge cluster-randomised trial. Lancet HIV. 2016;3:e539\u201348.","journal-title":"Lancet HIV"},{"issue":"6","key":"10861_CR35","first-page":"365","volume":"49","author":"L Wei","year":"2022","unstructured":"Wei L, Zhao Y, Gan XM, Zhao DC, Wu YS, Dou ZH, et al. Analysis on the timeliness of antiretroviral therapy among HIV-infected people in China, 2011\u20132020[J]. Inter J Epidemiol Infect Dis. 2022;49(6):365\u201370.","journal-title":"Inter J Epidemiol Infect Dis"},{"issue":"6","key":"10861_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002822","volume":"16","author":"O Tymejczyk","year":"2019","unstructured":"Tymejczyk O, Brazier E, Yiannoutsos CT, Vinikoor M, van Lettow M, Nalugoda F, et al. Changes in rapid HIV treatment initiation after national \u201ctreat all\u201d policy adoption in 6 sub-Saharan African countries: Regression discontinuity analysis. PLoS Med. 2019;16(6): e1002822.","journal-title":"PLoS Med"},{"issue":"6","key":"10861_CR37","doi-asserted-by":"publisher","first-page":"729","DOI":"10.4103\/ijmr.ijmr_239_23","volume":"156","author":"YW Subronto","year":"2022","unstructured":"Subronto YW, Kusmayanti NA, Januraga PP, Dewa Wirawan LN, Wisaksana R, Sukmaningrum E, et al. Simplified clinical algorithm for immediate antiretroviral therapy initiation: The HATI [HIV awal (early) Test & Treat in Indonesia] implementation research in Indonesia. Indian J Med Res. 2022;156(6):729\u201341.","journal-title":"Indian J Med Res"},{"key":"10861_CR38","unstructured":"Chinese Guidelines for Diagnosis and Treatment of HIV\/AIDS (2021). Chin J AIDS STD. 2021;27(11):1182\u20131201."},{"key":"10861_CR39","unstructured":"WHO. Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy. 2017. https:\/\/www.who.int\/publications\/i\/item\/9789241550062. Assessed 5 March 2024."},{"key":"10861_CR40","unstructured":"Department of Health South Africa. Implementation of the universal test and treat strategy for HIV positive patients and differentiated care for stable patients. 2017. https:\/\/sahivsoc.org\/Files\/22%208%2016%20Circular%20UTT%20%20%20Decongestion%20CCMT%20Directorate.pdf. Assessed 5 March 2024."},{"issue":"4","key":"10861_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003067","volume":"17","author":"S Floyd","year":"2020","unstructured":"Floyd S, Shanaube K, Yang B, Schaap A, Griffith S, Phiri M, et al. HIV testing and treatment coverage achieved after 4 years across 14 urban and peri-urban communities in Zambia and South Africa: An analysis of findings from the HPTN 071 (PopART) trial. PLOS Med. 2020;17(4): e1003067.","journal-title":"PLOS Med"},{"issue":"18","key":"10861_CR42","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.1097\/QAD.0000000000001250","volume":"30","author":"LB Brown","year":"2016","unstructured":"Brown LB, Havlir DV, Ayieko J, Mwangwa F, Owaraganise A, Kwarisiima D, et al. High levels of retention in care with streamlined care and universal test and treat in East Africa. AIDS. 2016;30(18):2855\u201364.","journal-title":"AIDS"},{"key":"10861_CR43","doi-asserted-by":"publisher","first-page":"e755","DOI":"10.1016\/S2352-3018(21)00186-7","volume":"8","author":"A Mody","year":"2021","unstructured":"Mody A, Sikazwe I, Namwase AS, Wa Mwanza M, Savory T, Mwila A, et al. Effects of implementing universal and rapid HIV treatment on initiation of antiretroviral therapy and retention in care in Zambia: a natural experiment using regression discontinuity. Lancet HIV. 2021;8:e755\u201365.","journal-title":"Lancet HIV"},{"issue":"12","key":"10861_CR44","first-page":"1547","volume":"37","author":"D He","year":"2022","unstructured":"He D, Fan HY, Liu WX, Zhang Y, Gao Y, Peng J, et al. Effectiveness of intensive prevention and control of mother to child transmission of AIDS in Liangshan. Sichuan Disease Surveillance. 2022;37(12):1547\u201351.","journal-title":"Sichuan Disease Surveillance"},{"issue":"6","key":"10861_CR45","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25543","volume":"23","author":"J Ross","year":"2020","unstructured":"Ross J, Ribakare M, Remera E, Murenzi G, Munyaneza A, Hoover DR, et al. High levels of viral load monitoring and viral suppression under Treat All in Rwanda - a cross-sectional study. J Int AIDS Soc. 2020;23(6): e25543.","journal-title":"J Int AIDS Soc"},{"key":"10861_CR46","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ijid.2020.05.097","volume":"97","author":"EK Maina","year":"2020","unstructured":"Maina EK, Mureithi H, Adan AA, Muriuki J, Lwembe RM, Bukusi EA. Incidences and factors associated with viral suppression or rebound among HIV patients on combination antiretroviral therapy from three counties in Kenya. Int J Infect Dis. 2020;97:151\u20138.","journal-title":"Int J Infect Dis"},{"issue":"1","key":"10861_CR47","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1186\/s12879-021-06490-0","volume":"21","author":"L Shi","year":"2021","unstructured":"Shi L, Tang W, Hu H, Qiu T, Marley G, Liu XY, et al. The impact of COVID-19 pandemic on HIV care continuum in Jiangsu, China. BMC Infect Dis. 2021;21(1):768.","journal-title":"BMC Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-10861-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-10861-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-10861-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T17:07:08Z","timestamp":1744391228000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-10861-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,11]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10861"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-10861-2","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,11]]},"assertion":[{"value":"2 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Institutional Review Board of National Center for AIDS\/STD Control and Prevention, Chinese Center for Disease Control and Prevention (X140121318) gave ethical approval for this study. Since all data were deidentifed and provided in the aggregated form, the informed consent was waived. All methods were performed in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable as all data are presented in the aggregate.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"507"}}